---
title: "Ascendis Pharma updates financial calendar ahead of quarterly results release and webcast"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295137614.md"
description: "Ascendis Pharma announced its financial calendar, stating it will release Q2 2026 results on August 13, 2026, before US market open. A live webcast and conference call will follow at 8:00 a.m. ET. Investors are invited to pre-register for the teleconference via the provided link."
datetime: "2026-08-06T20:07:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295137614.md)
  - [en](https://longbridge.com/en/news/295137614.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295137614.md)
generator: "portal-rs"
---

# Ascendis Pharma updates financial calendar ahead of quarterly results release and webcast

-   Ascendis Pharma will report Q2 2026 financial results on Aug. 13, 2026, before the US market open. \* A conference call, live webcast will follow at 8:00 a.m. ET on Aug. 13, 2026 via webcast (here). \* Investors can pre-register for the teleconference at registration link (here). Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascendis Pharma A/S published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608061601PRIMZONEFULLFEED9805523) on August 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [ASND.US](https://longbridge.com/en/quote/ASND.US.md)

## Related News & Research

- [Biomarin, Ascendis Reach Mutually Beneficial Agreement Ending Global Patent Disputes](https://longbridge.com/en/news/297515082.md)
- [Ascendis Announces Oral Presentation of Week 104 Data from Its Pivotal Trial of TransCon® CNP (Navepegritide) at ISDS 2026 | ASND Stock News](https://longbridge.com/en/news/296951291.md)
- [Oil-Dri updates financial calendar with earnings release, webcast schedule](https://longbridge.com/en/news/297691999.md)
- [This Ascendis Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday](https://longbridge.com/en/news/297205620.md)
- [Sildarvinnslan schedules investor webcast to present Q2 2026 results](https://longbridge.com/en/news/297017418.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**